Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - Celldex Therapeutics, Inc. | a2234429zex-32.htm |
| EX-31.2 - EX-31.2 - Celldex Therapeutics, Inc. | a2234429zex-31_2.htm |
| EX-31.1 - EX-31.1 - Celldex Therapeutics, Inc. | a2234429zex-31_1.htm |
| EX-21.1 - EX-21.1 - Celldex Therapeutics, Inc. | a2234429zex-21_1.htm |
| EX-10.28 - EX-10.28 - Celldex Therapeutics, Inc. | a2234429zex-10_28.htm |
| EX-10.27 - EX-10.27 - Celldex Therapeutics, Inc. | a2234429zex-10_27.htm |
| EX-10.25 - EX-10.25 - Celldex Therapeutics, Inc. | a2234429zex-10_25.htm |
| EX-10.24 - EX-10.24 - Celldex Therapeutics, Inc. | a2234429zex-10_24.htm |
| 10-K - 10-K - Celldex Therapeutics, Inc. | a2234429z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-219867, 333-219869, 333-205694, 333-189336, 333-151728 and 333-117602) and on Form S-3 (Nos. 333-214882 and 333-215747) of Celldex Therapeutics, Inc. of our report dated March 7, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston,
Massachusetts
March 7, 2018
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM